Kennedy Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-96,868
| Closed | -$5.91M | – | 594 |
|
|
2025
Q1 | $5.91M | Sell |
96,868
-7,883
| -8% | -$481K | 0.14% | 251 |
|
|
2024
Q4 | $5.92M | Buy |
104,751
+21,118
| +25% | +$1.19M | 0.13% | 277 |
|
|
2024
Q3 | $4.33M | Buy |
83,633
+3,821
| +5% | +$198K | 0.1% | 354 |
|
|
2024
Q2 | $3.31M | Buy |
79,812
+32,097
| +67% | +$1.33M | 0.07% | 424 |
|
|
2024
Q1 | $2.59M | Buy |
+47,715
| New | +$2.59M | 0.05% | 474 |
|
|
2020
Q1 | – | Sell |
-3,125
| Closed | -$201K | – | 669 |
|
|
2019
Q4 | $201K | Buy |
+3,125
| New | +$201K | ﹤0.01% | 681 |
|